XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Series A Redeemable Convertible Preferred Stock
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interests in Operating Subsidiaries
Beginning balance (in shares) at Dec. 31, 2022   350,000          
Beginning balance at Dec. 31, 2022   $ 19,924          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Conversion of Series A Redeemable Convertible Preferred Stock to common stock (in shares)   (350,000)          
Conversion of Series A Redeemable Convertible Preferred Stock to common stock   $ (23,154)          
Exercise of warrants $ 129,493   $ 31   $ 129,462    
Exercise of warrants (in shares)     31,506,849        
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value   $ 3,230          
Ending balance (in shares) at Sep. 30, 2023   0          
Ending balance at Sep. 30, 2023   $ 0          
Beginning balance (in shares) at Dec. 31, 2022     43,484,867        
Beginning balance at Dec. 31, 2022 269,322   $ 43 $ (98,258) 663,284 $ (306,789) $ 11,042
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income including noncontrolling interests in subsidiaries (6,570)         (7,696) 1,126
Distributions to noncontrolling interests in subsidiaries (1,126)           (1,126)
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value (3,230)       (3,230)    
Dividend on Series A Redeemable Convertible Preferred Stock (1,400)       (1,400)    
Conversion of Series A Redeemable Convertible Preferred Stock to common stock (in shares)     9,616,746        
Conversion of Series A Redeemable Convertible Preferred Stock to common stock 36,034   $ 10   36,024    
Stock options exercised (in shares)     67,500        
Stock options exercised 235       235    
Issuance of common stock from the Rights Offering, Shares     15,068,753        
Issuance of common stock from the Rights Offering 79,111   $ 15   79,096    
Issuance of common stock for vesting of restricted stock units (in shares)     313,351        
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)     (34,167)        
Shares withheld related to net share settlement of share-based awards (in shares)     (137,577)        
Shares withheld related to net share settlement of share-based awards (595)       (595)    
Compensation expense for share-based awards 2,324       2,324    
Ending balance (in shares) at Sep. 30, 2023     99,886,322        
Ending balance at Sep. 30, 2023 503,598   $ 99 (98,258) 905,200 (314,485) 11,042
Beginning balance (in shares) at Jun. 30, 2023   350,000          
Beginning balance at Jun. 30, 2023   $ 23,154          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Conversion of Series A Redeemable Convertible Preferred Stock to common stock (in shares)   (350,000)          
Conversion of Series A Redeemable Convertible Preferred Stock to common stock   $ (23,154)          
Exercise of warrants 129,493   $ 31   129,462    
Exercise of warrants (in shares)     31,506,849        
Ending balance (in shares) at Sep. 30, 2023   0          
Ending balance at Sep. 30, 2023   $ 0          
Beginning balance (in shares) at Jun. 30, 2023     58,754,795        
Beginning balance at Jun. 30, 2023 335,433   $ 58 (98,258) 738,712 (316,121) 11,042
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income including noncontrolling interests in subsidiaries 2,762         1,636 1,126
Distributions to noncontrolling interests in subsidiaries (1,126)           (1,126)
Conversion of Series A Redeemable Convertible Preferred Stock to common stock (in shares)     9,616,746        
Conversion of Series A Redeemable Convertible Preferred Stock to common stock 36,034   $ 10   36,024    
Stock options exercised (in shares)     7,932        
Stock options exercised 29       29    
Compensation expense for share-based awards 973       973    
Ending balance (in shares) at Sep. 30, 2023     99,886,322        
Ending balance at Sep. 30, 2023 503,598   $ 99 (98,258) 905,200 (314,485) 11,042
Beginning balance (in shares) at Dec. 31, 2023   0          
Beginning balance at Dec. 31, 2023   $ 0          
Ending balance (in shares) at Sep. 30, 2024   0          
Ending balance at Sep. 30, 2024   $ 0          
Beginning balance (in shares) at Dec. 31, 2023     99,895,473        
Beginning balance at Dec. 31, 2023 589,609   $ 100 (98,258) 906,153 (239,729) 21,343
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income including noncontrolling interests in subsidiaries (20,675)         (22,628) 1,953
Contributions from noncontrolling interests in subsidiaries 15,250           15,250
Change in ownership percentage in subsidiary 0       158   (158)
Stock options exercised (in shares)     61,667        
Stock options exercised 223       223    
Issuance of common stock for vesting of restricted stock units (in shares)     643,182        
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)     (2,802)        
Shares withheld related to net share settlement of share-based awards (in shares)     (222,061)        
Shares withheld related to net share settlement of share-based awards (1,068)       (1,068)    
Compensation expense for share-based awards 2,530       2,530    
Repurchase of common stock (in shares)     (1,537,122)        
Repurchase of common stock (7,303)   $ (1) (7,302)      
Ending balance (in shares) at Sep. 30, 2024     98,838,337        
Ending balance at Sep. 30, 2024 578,566   $ 99 (105,560) 907,996 (262,357) 38,388
Beginning balance (in shares) at Jun. 30, 2024   0          
Beginning balance at Jun. 30, 2024   $ 0          
Ending balance (in shares) at Sep. 30, 2024   0          
Ending balance at Sep. 30, 2024   $ 0          
Beginning balance (in shares) at Jun. 30, 2024     100,375,459        
Beginning balance at Jun. 30, 2024 596,745   $ 100 (98,258) 907,215 (248,361) 36,049
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income including noncontrolling interests in subsidiaries (11,657)         (13,996) 2,339
Compensation expense for share-based awards 781       781    
Repurchase of common stock (in shares)     (1,537,122)        
Repurchase of common stock (7,303)   $ (1) (7,302)      
Ending balance (in shares) at Sep. 30, 2024     98,838,337        
Ending balance at Sep. 30, 2024 $ 578,566   $ 99 $ (105,560) $ 907,996 $ (262,357) $ 38,388